Skip to main content
Equibles

MORGAN STANLEY

Position in EOCN — Galmed Pharmaceuticals Ltd.

CIK 895421 NEW YORK, NY
Back to EOCN Full portfolio

Position in EOCN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3
+$3 QoQ
Shares Held
56
-64.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 12 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in EOCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. EOCN ranks #513 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in EOCN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3 56
2026-03-31 — 157
2025-12-31 — 298
2025-09-30 — 98
2025-06-30 — 33,573
2025-03-31 — 7,385
2024-12-31 — 12,530
2024-09-30 — 104
2024-06-30 — 36,213
2024-03-31 — 14,498
2023-12-31 — 82,468
2023-09-30 — 20,032
2023-06-30 — 12,498
2023-03-31 — 204,245
2022-12-31 — 180,724
2022-09-30 — 189,620
2022-06-30 — 195,699
2022-03-31 — 165,300
2021-12-31 — 160,800
2021-09-30 — 164,500
2021-06-30 — 184,200
2021-03-31 — 185,552
2020-12-31 — 162,352
2020-09-30 — 130,165
2020-06-30 — 110,703
2020-03-31 — 77,552